These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 894682)

  • 21. Comparison of naltrexone, 6alpha-naltrexol, and 6beta-naltrexol in morphine-dependent and in nondependent rhesus monkeys.
    Li JX; McMahon LR; France CP
    Psychopharmacology (Berl); 2008 Jan; 195(4):479-86. PubMed ID: 17874317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence.
    Wang D; Raehal KM; Bilsky EJ; Sadée W
    J Neurochem; 2001 Jun; 77(6):1590-600. PubMed ID: 11413242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary characterization of enzymes for reduction of naloxone and naltrexone in rabbit and chicken liver.
    Roerig S; Fujimoto JM; Wang RI; Pollock SH; Lange D
    Drug Metab Dispos; 1976; 4(1):53-8. PubMed ID: 56258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted michael acceptor ligand.
    Koolpe GA; Nelson WL; Gioannini TL; Angel L; Simon EJ
    J Med Chem; 1984 Dec; 27(12):1718-23. PubMed ID: 6209395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereochemistry of novel delta selective opiate antagonists.
    Kolb VM; Hua DH; Duax WL
    NIDA Res Monogr; 1986; 75():45-8. PubMed ID: 2828990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular aspects of pharmacological activity of naltrexone and naloxone].
    Golovko AI; Golovko SI; Leont'eva LV; Romanenko OI; Konoplin DA
    Eksp Klin Farmakol; 2003; 66(1):71-8. PubMed ID: 12683088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat.
    Koob GF; Pettit HO; Ettenberg A; Bloom FE
    J Pharmacol Exp Ther; 1984 May; 229(2):481-6. PubMed ID: 6716270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of naloxone and naltrexone-derived hybrid opioids.
    Nassim BE; Wang ML
    Med Chem; 2012 Jul; 8(4):683-9. PubMed ID: 22530908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential in vivo potencies of naltrexone and 6beta-naltrexol in the monkey.
    Ko MC; Divin MF; Lee H; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2006 Feb; 316(2):772-9. PubMed ID: 16258020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of a new opiate antagonist, nalmefene, to rat brain membranes.
    Michel ME; Bolger G; Weissman BA
    Methods Find Exp Clin Pharmacol; 1985 Apr; 7(4):175-7. PubMed ID: 2991678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of C-6 chirality in conferring irreversible opioid antagonism to naltrexone-derived affinity labels.
    Sayre LM; Larson DL; Fries DS; Takemori AE; Portoghese PS
    J Med Chem; 1983 Sep; 26(9):1229-35. PubMed ID: 6310111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quaternary narcotic antagonists' relative ability to prevent antinociception and gastrointestinal transit inhibition in morphine-treated rats as an index of peripheral selectivity.
    Bianchi G; Fiocchi R; Tavani A; Manara L
    Life Sci; 1982 May; 30(22):1875-83. PubMed ID: 7109826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological properties of bivalent ligands containing butorphan linked to nalbuphine, naltrexone, and naloxone at mu, delta, and kappa opioid receptors.
    Peng X; Knapp BI; Bidlack JM; Neumeyer JL
    J Med Chem; 2007 May; 50(9):2254-8. PubMed ID: 17407276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quaternary derivatives of narcotic antagonists: stereochemical requirements at the chiral nitrogen for in vitro and in vivo activity.
    Bianchetti A; Nisato D; Sacilotto R; Dragonetti M; Picerno N; Tarantino A; Manara L; Angel LM; Simon EJ
    Life Sci; 1983; 33 Suppl 1():415-8. PubMed ID: 6319895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Historical perspective on the chemistry and development of naltrexone.
    Archer S
    NIDA Res Monogr; 1981; 28():3-10. PubMed ID: 6791011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists.
    Russell J; Bass P; Goldberg LI; Schuster CR; Merz H
    Eur J Pharmacol; 1982 Mar; 78(3):255-61. PubMed ID: 7200037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quaternary naltrexone: evidence for the central mediation of discriminative stimulus effects of narcotic agonists and antagonists.
    Valentino RJ; Herling S; Woods JH; Medzihradsky F; Merz H
    J Pharmacol Exp Ther; 1981 Jun; 217(3):652-9. PubMed ID: 6262493
    [No Abstract]   [Full Text] [Related]  

  • 39. Morphine analgesia after intrathecal administration of a narcotic agonist, chloroxymorphamine and antagonist, chlornaltrexamine.
    Larson AA; Armstrong MJ
    Eur J Pharmacol; 1980 Nov; 68(1):25-31. PubMed ID: 6161013
    [No Abstract]   [Full Text] [Related]  

  • 40. Carbon-13 nuclear magnetic resonance identification of 2-hydroxy-3-O-methyl-6beta-naltrexol as a minor naltrexone metabolite.
    Brine GA; Brine DR; Welch CD; Bondeson VC; Carroll FI
    Res Commun Chem Pathol Pharmacol; 1978 Dec; 22(3):455-64. PubMed ID: 734225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.